|
|
||||||||
CUTTING EDGE |




*
Institute of Medical Microbiology, Hannover Medical School, Hannover, Germany; and Departments of
Pulmonary Pharmacology and
Molecular Biology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406
The interaction of human
anaphylatoxin C4a with the guinea pig (gp) and human (hu) C3a receptors
(C3aR) was analyzed using human rC4a, which exhibited C4a-specific
activity on guinea pig platelets. A gpC3aR of 475 residues with a large
second extracellular loop and a peptide sequence
60% identical to
the huC3aR was isolated from a genomic DNA library and found to be
expressed in guinea pig heart, lung, and spleen. HEK-293 cells
cotransfected with this clone, and a cDNA encoding G
-16 specifically
bound (Kd = 1.6 ± 0.7 nM) and responded
functionally to C3a with an intracellular calcium mobilization
(ED50 = 0.18 ± 0.02 nM). Human rC4a weakly bound to
both the hu- and gpC3aR (IC50 > 1 µM). However, only
HEK-293 cells expressing the gpC3aR responded functionally to rC4a
(ED50 = 8.7 ± 0.52 nM), while cells expressing the
huC3aR did not (c
1 µM). Thus, through an
interaction with the C3aR, huC4a may elicit anaphylatoxic effects in
guinea pigs but not in man.
This article has been cited by other articles:
![]() |
S. A. Cain and P. N. Monk The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74 J. Biol. Chem., February 22, 2002; 277(9): 7165 - 7169. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ames, D. Lee, J. J. Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, et al. Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models J. Immunol., May 15, 2001; 166(10): 6341 - 6348. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bautsch, H.-G. Hoymann, Q. Zhang, I. Meier-Wiedenbach, U. Raschke, R. S. Ames, B. Sohns, N. Flemme, A. Meyer zu Vilsendorf, M. Grove, et al. Cutting Edge: Guinea Pigs with a Natural C3a-Receptor Defect Exhibit Decreased Bronchoconstriction in Allergic Airway Disease: Evidence for an Involvement of the C3a Anaphylatoxin in the Pathogenesis of Asthma J. Immunol., November 15, 2000; 165(10): 5401 - 5405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Crass, R. S. Ames, H. M. Sarau, M. A. Tornetta, J. J. Foley, J. Kohl, A. Klos, and W. Bautsch Chimeric Receptors of the Human C3a Receptor and C5a Receptor (CD88) J. Biol. Chem., March 26, 1999; 274(13): 8367 - 8370. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |